Avodart, Prostate Drug, Found to Reduce Cancer Risk
Monday, April 27, 2009 - 23:00
in Health & Medicine
A drug from GlaxoSmithKline, Avodart, reduces the risk of prostate cancer, according to the results of a new large clinical study.
Read the whole article on NY Times Health
More from NY Times Health
Related
- Data re-analysis shows drug finasteride reduces risk for most prostate cancersTue, 20 May 2008, 13:35:35 EDT
- Stanford study bolsters case for preventive prostate cancer treatmentTue, 7 Jul 2009, 15:37:50 EDT
- New drug shows promise in treating drug-resistant prostate cancerFri, 10 Apr 2009, 10:24:39 EDT
- Neither vitamin C or E associated with reduced risk of prostate cancer, or other cancersTue, 9 Dec 2008, 16:34:43 EST
- Statins may exert influence on prostate cancer growth by reducing inflammationSun, 26 Apr 2009, 0:30:29 EDT